Alternative Response Criteria (Choi, European association for the study of the liver, and modified Response Evaluation Criteria in Solid Tumors [RECIST]) Versus RECIST 1.1 in patients with advanced hepatocellular carcinoma treated with sorafenib. (Q37698184)
Jump to navigation
Jump to search
scientific article published on 20 March 2014
Language | Label | Description | Also known as |
---|---|---|---|
English | Alternative Response Criteria (Choi, European association for the study of the liver, and modified Response Evaluation Criteria in Solid Tumors [RECIST]) Versus RECIST 1.1 in patients with advanced hepatocellular carcinoma treated with sorafenib. |
scientific article published on 20 March 2014 |
Statements
Alternative Response Criteria (Choi, European association for the study of the liver, and modified Response Evaluation Criteria in Solid Tumors [RECIST]) Versus RECIST 1.1 in patients with advanced hepatocellular carcinoma treated with sorafenib (English)
Maxime Ronot
Johanna Wassermann
Onorina Bruno
Chantal Dreyer
Béatrice Larroque
Valérie Vilgrain
Jacques Belghiti
1 reference